← Back to directory

Jonathan Z. Li

Researcher Next ID · RN-042846

Researcher · Immunology and Microbiology

Brigham and Women's Hospital

Boston, New Zealand

Accepting doctoral researchersFunding unknown
Works count
332
Citation count
17,634
H-index
60
i10-index
179

Research interests

Immunology and Microbiology
Medicine
SARS-CoV-2 and COVID-19 Research
HIV Research and Treatment
COVID-19 Clinical Research Studies
HIV/AIDS Research and Interventions
HIV/AIDS drug development and treatment

Publications

  • Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae

    Clinical Infectious Diseases · 2022 · 10.1093/cid/ciac722

  • A lab-on-a-chip for the concurrent electrochemical detection of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in saliva and plasma

    Nature Biomedical Engineering · 2022 · 10.1038/s41551-022-00919-w

  • SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms

    Cell · 2021 · 10.1016/j.cell.2021.03.027

  • Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

    Science · 2021 · 10.1126/science.abf9302

  • Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic

    JAMA Network Open · 2020 · 10.1001/jamanetworkopen.2020.30455

  • SARS-CoV-2 viral load is associated with increased disease severity and mortality

    Nature Communications · 2020 · https://doi.org/10.1038/s41467-020-19057-5

  • Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

    Cell · 2020 · 10.1016/j.cell.2020.08.025

  • Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

    Science · 2020 · 10.1126/science.abd4250

  • Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing

    New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmc2026172

  • Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

    New England Journal of Medicine · 2020 · 10.1056/nejmc2031364

  • Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses

    The Journal of Pediatrics · 2020 · 10.1016/j.jpeds.2020.08.037

  • Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

    The Lancet HIV · 2019 · https://doi.org/10.1016/s2352-3018(19)30052-9

  • Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy

    Journal of Clinical Investigation · 2019 · 10.1172/jci124291

  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

    The Journal of Infectious Diseases · 2018 · 10.1093/infdis/jiy479

  • The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption

    AIDS · 2015 · 10.1097/qad.0000000000000953

  • Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells

    Journal of Virology · 2014 · 10.1128/jvi.01046-14

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation

    Annals of Internal Medicine · 2014 · 10.7326/m14-1027

  • HIV-1 persistence in CD4+ T cells with stem cell–like properties

    Nature Medicine · 2014 · 10.1038/nm.3445

  • Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure

    JAMA · 2011 · 10.1001/jama.2011.375

Current projects

    No projects listed.